Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
Anesthesiologists compare mask ventilation adequacy with endotracheal intubation and laryngeal mask airway for pediatric patients
The paramedic-designed product is a self-administering medication device that looks and tastes like a lollipop
The paramedic allegedly diverted narcotics and refilled the vials with saline; a criminal investigation is underway
The family of a teen who died after an esophageal intubation has started the ‘Do It For Drew’ foundation to prevent another tragic death
Naloxone will be available without a prescription in Kroger’s pharmacies across Ohio and northern Kentucky
All of the deaths have occurred since Jan. 29; public officials call the heroin a death sentence
What is the clinical obligation vs. legal obligation when the standard of care changes for cardiac arrest treatment?
The Fast Track program facilitates the development and review of drugs
Make every assessment question count using this strategy to quickly assess respiratory patients who are unable to speak in phrases or sentences
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.